Detection of fms-oncogene-specific tyrosine kinase activity in human leukemia cells.
The c-fms protooncogene encodes the receptor for the colony-stimulating factor 1 of macrophages. Its transforming counterpart, the v-fms oncogene has previously been recognized as the transforming gene of the McDonough strain of feline sarcoma virus. We have isolated rabbit antisera against a 115-kDa recombinant polypeptide containing the 926 carboxy-terminal amino acids of the v-fms protein. All antibodies recognized the cytoplasmic domain of the v-fms protein, which is 95% homologous to the corresponding domain of human c-fms proteins. These sera were applied in a survey of various human cancer cell lines, such as peripheral blood mononuclear (HL60) and choriocarcinoma (BeWo) cells, as well as leukemic cells from 58 patients with acute myelocytic, chronic myelocytic or acute lymphocytic leukemias (AML, CML, ALL). Significantly enhanced levels of fms-specific tyrosine kinase activity were detected in 12-O-tetradecanoylphorbol-13-acetate-induced HL60 and in BeWo cells, and in 7 out of 24 samples from AML patients, whereas no activity could be detected in 9 ALL or in 25 CML cell preparations. The AML cells were classified according to the FAB criteria. The highest incidence of increased fms activity was found in cells assigned to the M4 class (four out of five cases). While no activity was found in material belonging to FAB classes M2 or M3, one of the two cases of the M5 class was kinase-positive. Interestingly, two out of seven cases of the M1 class cells exhibited enhanced levels of fms kinase. These data suggest that the determination of the fms kinase may be useful to subdivide the M1 class of the FAB classification into monocytic and non-monocytic precursor leukemia cells.
Tamura
T
T
Institut für Medizinische Virologie, Justus-Liebig-Universität Giessen, Federal Republic of Germany.
Brost
H
H
Käbisch
A
A
Lampert
F
F
Hadwiger-Fangmeier
A
A
Niemann
H
H
D000818:Animals; D004926:Escherichia coli / Q000032:analysis; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D007938:Leukemia / Q000201:enzymology*; D016281:Oncogene Protein gp140(v-fms); D011233:Precipitin Tests; D011505:Protein-Tyrosine Kinases / Q000032:analysis*; D011518:Proto-Oncogene Proteins / Q000032:analysis* / Q000276:immunology; D011817:Rabbits; D016186:Receptor, Macrophage Colony-Stimulating Factor; D012191:Retroviridae Proteins / Q000032:analysis / Q000276:immunology
D007106:Immune Sera; D016281:Oncogene Protein gp140(v-fms); D011518:Proto-Oncogene Proteins; D012191:Retroviridae Proteins; D011505:Protein-Tyrosine Kinases; D016186:Receptor, Macrophage Colony-Stimulating Factor